BMAL1 and steatosis: This was manifested by the development of steatosis, an 18% increase in hepatocyte area, a 30% decrease in the proportion of binucleated hepatocytes, activation of cellular senescence markers (p16, p21) and stress markers (p53), and suppression of the expression of circadian transcription factors BMAL1 and CLOCK.